A Phase II, Randomized, Open-Label, Parallel-Group Study to Evaluate the Efficacy and Safety of Autologous Dendritic Cell Vaccination (ADCV01) as an Add-On Treatment for Primary Glioblastoma Multiforme (GBM) Patients

Efficacy And Safety ◽

Autologous Dendritic Cell ◽

Open Label ◽

Primary Glioblastoma ◽

Parallel Group Study ◽

A randomized, open-label, standard controlled, parallel group study of efficacy and safety of baclofen, and chlordiazepoxide in uncomplicated alcohol withdrawal syndrome

Biomedical Journal ◽

10.1016/j.bj.2015.09.002 ◽

2016 ◽

Vol 39 (1) ◽

pp. 72-80 ◽

Cited By ~ 16

Author(s):

K. Girish ◽

K. Vikram Reddy ◽

Lakshmi V. Pandit ◽

H.P. Pundarikaksha ◽

R. Vijendra ◽

...

Keyword(s):

Alcohol Withdrawal ◽

Withdrawal Syndrome ◽

Alcohol Withdrawal Syndrome ◽

Efficacy And Safety ◽

Open Label ◽

Parallel Group Study ◽

Autologous dendritic cell vaccination (DCVAC/OvCa) added to standard of care therapy in three open-label randomized phase 2 studies in women with advanced stage ovarian cancer (OC).

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.tps3134 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. TPS3134-TPS3134

Author(s):

Lukas Rob ◽

Jirina Bartunkova ◽

David Cibula ◽

Pawel Knapp ◽

Zuzana Namestkova ◽

...

Keyword(s):

Ovarian Cancer ◽

Dendritic Cell ◽

Standard Of Care ◽

Advanced Stage ◽

Phase 2 ◽

Autologous Dendritic Cell ◽

Open Label ◽

Randomized Phase 2

A multinational, multicenter, open-label, controlled, randomised, parallel group study to evaluate the efficacy and safety of EMD 121974 and gemcitabine or gemcitabine alone in patients with advanced, unresectable pancreatic cancer

http://isrctn.org/> ◽

10.1186/isrctn13413322 ◽

2013 ◽

Author(s):

Helmut Friess

Keyword(s):

Pancreatic Cancer ◽

Unresectable Pancreatic Cancer ◽

Efficacy And Safety ◽

Open Label ◽

Parallel Group Study ◽

A 24‐week multicentre, randomized, open‐label, parallel‐group study comparing the efficacy and safety of ixekizumab vs. fumaric acid esters and methotrexate in patients with moderate‐to‐severe plaque psoriasis naive to systemic treatment

British Journal of Dermatology ◽

10.1111/bjd.18384 ◽

2019 ◽

Vol 182 (4) ◽

pp. 869-879 ◽

Cited By ~ 6

Author(s):

K. Reich ◽

M. Augustin ◽

D. Thaçi ◽

A. Pinter ◽

A. Leutz ◽

...

Keyword(s):

Fumaric Acid ◽

Plaque Psoriasis ◽

Systemic Treatment ◽

Efficacy And Safety ◽

Open Label ◽

Severe Plaque Psoriasis ◽

Fumaric Acid Esters ◽

Parallel Group Study ◽

Parallel Group ◽

Acid Esters

Efficacy and safety of guaifenesin for upper back, neck, and shoulder pain: a Phase II proof-of-concept, multicenter, placebo-controlled, repeat-dose, parallel-group study

Journal of Pain Research ◽

10.2147/jpr.s126296 ◽

2017 ◽

Vol Volume 10 ◽

pp. 669-678

Author(s):

Agron Collaku ◽

Yong Yue ◽

Kenneth Reed

Keyword(s):

Shoulder Pain ◽

Phase Ii ◽

Repeat Dose ◽

Proof Of Concept ◽

Efficacy And Safety ◽

Parallel Group Study ◽

Parallel Group ◽

Neck And Shoulder Pain

Long-term efficacy and safety of incobotulinumtoxinA and conventional treatment of poststroke arm spasticity: a prospective, non-interventional, open-label, parallel-group study

BMJ Open ◽

10.1136/bmjopen-2015-009358 ◽

2015 ◽

Vol 5 (12) ◽

pp. e009358 ◽

Cited By ~ 12

Author(s):

Dirk Dressler ◽

Reinhard Rychlik ◽

Fabian Kreimendahl ◽

Nicole Schnur ◽

Judith Lambert-Baumann

Keyword(s):

Conventional Treatment ◽

Efficacy And Safety ◽

Open Label ◽

Term Efficacy ◽

Parallel Group Study ◽

A Randomized, Open-Label, Parallel Group Study to Evaluate the Efficacy and Safety of Proactive Management in Pediatric Subjects with Moderate to Severe Atopic Dermatitis

Journal of Allergy and Clinical Immunology ◽

10.1016/j.jaci.2012.12.1030 ◽

2013 ◽

Vol 131 (2) ◽

pp. AB101

Author(s):

Tatsuki Fukuie ◽

Ichiro Nomura ◽

Masami Narita ◽

Tsukasa Suzuki ◽

Iwao Tajima ◽

...

Keyword(s):

Atopic Dermatitis ◽

Severe Atopic Dermatitis ◽

Efficacy And Safety ◽

Open Label ◽

Proactive Management ◽

Parallel Group Study ◽

A randomised open label parallel group study on evaluation of efficacy and safety of gemifloxacin versus cefpodoxime in chronic obstructive pulmonary disease patients.

International Journal of Pharma and Bio Sciences ◽

10.22376/ijpbs.2017.8.2.p324-331 ◽

2017 ◽

Vol 8 (2) ◽

Author(s):

RENU KA ◽

VASANTHI C ◽

DARLING CHELLATHAI

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Chronic Obstructive ◽

Efficacy And Safety ◽

Open Label ◽

Obstructive Pulmonary Disease ◽

Parallel Group Study ◽

Abstract P5-16-03: Phase II study of autologous dendritic cell vaccination in patients with HER2 negative breast cancer combined with neoadjuvant chemotherapy

10.1158/0008-5472.sabcs12-p5-16-03 ◽

2012 ◽

Author(s):

A Castillo ◽

E Salgado ◽

S Inoges ◽

E Arevalo ◽

E Castañon ◽

...

Keyword(s):

Breast Cancer ◽

Dendritic Cell ◽

Neoadjuvant Chemotherapy ◽

Phase Ii ◽

Phase Ii Study ◽

Autologous Dendritic Cell

A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients

Journal of Translational Medicine ◽

10.1186/s12967-017-1202-z ◽

2017 ◽

Vol 15 (1) ◽

Cited By ~ 41

Author(s):

Susana Inogés ◽

Sonia Tejada ◽

Ascensión López-Díaz de Cerio ◽

Jaime Gállego Pérez-Larraya ◽

Jaime Espinós ◽

...

Keyword(s):

Dendritic Cell ◽

Phase Ii ◽

Phase Ii Trial ◽

Newly Diagnosed ◽

Autologous Dendritic Cell ◽

Guided Surgery ◽

Fluorescence Guided Surgery ◽

Newly Diagnosed Glioblastoma